Cite

HARVARD Citation

    Rapposelli, I. et al. (2021). Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib. Liver international. pp. 2997-3008. [Online]. 
  
Back to record